Is a complete EBR/CYAD research report available?

No complete published report is available for ebr/CYAD (EBR/CYAD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

EBR/CYAD (EBR/CYAD)

Euronext Brussels: EBR/CYAD · EUR

€0.21

+0.00 (0.0%)· Recorded snapshot

Market cap	9.4M
Revenue (ttm)	7K
Net income (ttm)	3.3M
EPS (ttm)	€0.07
Shares out	44.8M
P/E (trailing)	3.1x
Volume	120
Beta	1.25

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 7K
Net income (ttm): 3.3M
EPS (ttm): €0.07
P/E (trailing): 3.1x
Market cap: 9.4M

Metric	Value
Amount currency	EUR
Country	Belgium
Country code	BE
Earnings date	2027-09-24
Employees	5
Employees change	-14
Employees growth	-73.68%
Enterprise value	EUR 9.3M
Exchange	Euronext Brussels
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2004
Industry	Biotechnology
Is primary listing	Yes
ISIN number	BE0974260896
Last earnings date	2026-09-23
Last refreshed	2026-10-29
Market cap	EUR 9.4M
Next earnings date	2027-09-24
Price	EUR 0.21
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	ebr/CYAD
Website	https://celyad.com

Metric

Value

Amount currency

EUR

Country

Belgium

Country code

Earnings date

2027-09-24

Employees

Employees change

-14

Employees growth

-73.68%

Enterprise value

EUR 9.3M

Exchange

Euronext Brussels

Financial currency

EUR

Financial report date

2026-06-30

First seen

2026-05-10

Fiscal year end

December

Founded

2004

Industry

Biotechnology

Is primary listing

Yes

ISIN number

BE0974260896

Last earnings date

2026-09-23

Last refreshed

2026-10-29

Market cap

EUR 9.4M

Next earnings date

2027-09-24

Price

EUR 0.21

Price currency

EUR

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-29

Symbol

ebr/CYAD

Website

https://celyad.com

Metric	Value
Earnings yield	32.76%
EV/Earnings	2.82x
EV/EBIT	9.97x
EV/EBITDA	10.51x
FCF / EV yield	-55.04%
FCF yield	-54.33%
Graham number	0.20841
Graham upside	-0.76%
Industry P/E	28.77x
P/B ratio	7.48x
P/E ratio	3.05x
P/S ratio	1,342.86x
Price / tangible book value	7.56x
Price/EBITDA ratio	12.13x
Sector forward P/E	22.94x
Sector P/E	29.62x

Metric

Value

Earnings yield

32.76%

EV/Earnings

2.82x

EV/EBIT

9.97x

EV/EBITDA

10.51x

FCF / EV yield

-55.04%

FCF yield

-54.33%

Graham number

0.20841

Graham upside

-0.76%

Industry P/E

28.77x

P/B ratio

7.48x

P/E ratio

3.05x

P/S ratio

1,342.86x

Price / tangible book value

7.56x

Price/EBITDA ratio

12.13x

Sector forward P/E

22.94x

Sector P/E

29.62x

Metric	Value
EBIT margin	13,300%
EBITDA margin	11,071.43%
Gross margin	3,357.14%
Operating margin	13,300%
Pretax margin	47,071.43%
Profit margin	47,071.43%
Profit per employee	EUR 659,000
Profitable years	1
Revenue per employee	EUR 1,400
ROA	14.51%
ROA (5Y)	-25.95%
ROCE	66.74%
ROE (5Y)	-103.09%
SBC / revenue	1,271.43%

Metric

Value

EBIT margin

13,300%

EBITDA margin

11,071.43%

Gross margin

3,357.14%

Operating margin

13,300%

Pretax margin

47,071.43%

Profit margin

47,071.43%

Profit per employee

EUR 659,000

Profitable years

Revenue per employee

EUR 1,400

ROA

14.51%

ROA (5Y)

-25.95%

ROCE

66.74%

ROE (5Y)

-103.09%

SBC / revenue

1,271.43%

Metric	Value
EPS growth quarters	7
EPS growth years	3
Net income growth quarters	2
Net income growth years	3
Revenue growth	-96.24%
Revenue growth 10Y	-16.6%
Revenue growth 3Y	-45.81%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

-96.24%

Revenue growth 10Y

-16.6%

Revenue growth 3Y

-45.81%

Revenue growth years

Metric	Value
Depreciation and amortization	EUR -156,000
EBIT	EUR 931,000
EBITDA	EUR 775,000
EPS	EUR 0.07
FCF per share	EUR -0.11
Financing cash flow	EUR 1.4M
Free cash flow	EUR -5.1M
Free cash flow minus SBC	EUR -5.2M
Gross profit	EUR 235,000
Investing cash flow	EUR 3M
Net borrowing	EUR -53,000
Net cash flow	EUR -669,000
Net income	EUR 3.3M
Operating cash flow minus SBC	EUR -5.2M
Operating income	EUR 931,000
Revenue	EUR 7,000
Stock-based compensation	EUR 89,000

Metric

Value

Depreciation and amortization

EUR -156,000

EBIT

EUR 931,000

EBITDA

EUR 775,000

EPS

EUR 0.07

FCF per share

EUR -0.11

Financing cash flow

EUR 1.4M

Free cash flow

EUR -5.1M

Free cash flow minus SBC

EUR -5.2M

Gross profit

EUR 235,000

Investing cash flow

EUR 3M

Net borrowing

EUR -53,000

Net cash flow

EUR -669,000

Net income

EUR 3.3M

Operating cash flow minus SBC

EUR -5.2M

Operating income

EUR 931,000

Revenue

EUR 7,000

Stock-based compensation

EUR 89,000

Metric	Value
Altman Z-Score	-211.22
Book value per share	EUR 0.03
Debt / equity	0
Interest coverage	21.16
Long-term assets	EUR 1.5M
Long-term liabilities	EUR 139,000
Net cash (debt)	EUR 121,000
Net cash / market cap	1.29%
Net debt / EBITDA	-0.16
Net debt / equity	-0.1
Piotroski F-Score	4
Shareholders' equity	EUR 1.3M
Tangible book value	EUR 1.2M
Tangible book value per share	EUR 0.03
Total assets	EUR 2.3M
Total cash	EUR 121,000
Total debt	EUR 0
Total liabilities	EUR 1.1M
WACC	11.13%

Metric

Value

Altman Z-Score

-211.22

Book value per share

EUR 0.03

Debt / equity

Interest coverage

21.16

Long-term assets

EUR 1.5M

Long-term liabilities

EUR 139,000

Net cash (debt)

EUR 121,000

Net cash / market cap

1.29%

Net debt / EBITDA

-0.16

Net debt / equity

-0.1

Piotroski F-Score

Shareholders' equity

EUR 1.3M

Tangible book value

EUR 1.2M

Tangible book value per share

EUR 0.03

Total assets

EUR 2.3M

Total cash

EUR 121,000

Total debt

EUR 0

Total liabilities

EUR 1.1M

WACC

11.13%

Metric	Value
Asset turnover	0
Current assets	EUR 871,000
Current liabilities	EUR 930,000
Current ratio	0.94
Net working capital	EUR -180,000
Quick ratio	0.91
Working capital	EUR -59,000
Working capital turnover	-0.01

Metric

Value

Asset turnover

Current assets

EUR 871,000

Current liabilities

EUR 930,000

Current ratio

0.94

Net working capital

EUR -180,000

Quick ratio

0.91

Working capital

EUR -59,000

Working capital turnover

-0.01

Metric	Value
Buyback yield / dilution	-15.71%
Shareholder yield	-15.71%

Metric

Value

Buyback yield / dilution

-15.71%

Shareholder yield

-15.71%

Metric	Value
10Y price change	-98.61%
10Y return CAGR	-34.8%
10Y total return	-98.61%
150-day SMA	EUR 0.27
1D price change	0%
1M price change	-8.44%
1M total return	-8.44%
1W price change	-0.96%
1W total return	-0.96%
1Y price change	-1.9%
1Y return CAGR	-1.91%
1Y total return	-1.9%
20-day SMA	EUR 0.21
200-day SMA	EUR 0.27
3M price change	-28.72%
3M total return	-28.72%
3Y price change	-65.78%
3Y return CAGR	-30.05%
3Y total return	-65.78%
50-day SMA	EUR 0.24
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 0.65
52-week high date	2026-02-17
52-week low	EUR 0.16
52-week low date	2025-12-30
5Y price change	-94.7%
5Y return CAGR	-44.43%
5Y total return	-94.7%
6M price change	-35.22%
6M total return	-35.22%
All-time high	EUR 70.95
All-time high date	2015-05-25
All-time low	EUR 0.16
All-time low date	2025-12-30
Average true range (ATR)	EUR 0.02
Average volume	7.2K
Beta (1Y)	1.61
Beta (2Y)	0.51
Beta (5Y)	1.25
Change from 52-week high	-67.69%
Change from 52-week low	31.25%
Change from all-time high	-99.71%
Change from all-time low	28.75%
Change from open	0%
Day's gap	0%
Dollar volume	EUR 25.2
High price	EUR 0.21
Low price	EUR 0.21
Monthly RSI	37.1
Open price	EUR 0.21
Position in 52-week range	100%
Previous close	EUR 0.21
Price vs 150-day SMA	-22.59%
Price vs 20-day SMA	-4.1%
Price vs 200-day SMA	-24.68%
Price vs 50-day SMA	-13.15%
Relative volume	0.02
RSI	44.31
Sharpe ratio	0.44
Sharpe ratio (3Y)	0.19
Sharpe ratio (5Y)	-0
Sortino ratio	0.91
Sortino ratio (3Y)	0.47
Sortino ratio (5Y)	0.06
Volume	120
Weekly RSI	38.28
YTD price change	21.18%
YTD total return	21.18%

Metric

Value

10Y price change

-98.61%

10Y return CAGR

-34.8%

10Y total return

-98.61%

150-day SMA

EUR 0.27

1D price change

1M price change

-8.44%

1M total return

-8.44%

1W price change

-0.96%

1W total return

-0.96%

1Y price change

-1.9%

1Y return CAGR

-1.91%

1Y total return

-1.9%

20-day SMA

EUR 0.21

200-day SMA

EUR 0.27

3M price change

-28.72%

3M total return

-28.72%

3Y price change

-65.78%

3Y return CAGR

-30.05%

3Y total return

-65.78%

50-day SMA

EUR 0.24

50-day SMA vs 200-day SMA

50under200

52-week high

EUR 0.65

52-week high date

2026-02-17

52-week low

EUR 0.16

52-week low date

2025-12-30

5Y price change

-94.7%

5Y return CAGR

-44.43%

5Y total return

-94.7%

6M price change

-35.22%

6M total return

-35.22%

All-time high

EUR 70.95

All-time high date

2015-05-25

All-time low

EUR 0.16

All-time low date

2025-12-30

Average true range (ATR)

EUR 0.02

Average volume

7.2K

Beta (1Y)

1.61

Beta (2Y)

0.51

Beta (5Y)

1.25

Change from 52-week high

-67.69%

Change from 52-week low

31.25%

Change from all-time high

-99.71%

Change from all-time low

28.75%

Change from open

Day's gap

Dollar volume

EUR 25.2

High price

EUR 0.21

Low price

EUR 0.21

Monthly RSI

37.1

Open price

EUR 0.21

Position in 52-week range

100%

Previous close

EUR 0.21

Price vs 150-day SMA

-22.59%

Price vs 20-day SMA

-4.1%

Price vs 200-day SMA

-24.68%

Price vs 50-day SMA

-13.15%

Relative volume

0.02

RSI

44.31

Sharpe ratio

0.44

Sharpe ratio (3Y)

0.19

Sharpe ratio (5Y)

-0

Sortino ratio

0.91

Sortino ratio (3Y)

0.47

Sortino ratio (5Y)

0.06

Volume

120

Weekly RSI

38.28

YTD price change

21.18%

YTD total return

21.18%

Metric	Value
Float	14.2M
Shares change (QoQ)	-12.42%
Shares change (YoY)	15.71%
Shares held by insiders	0.45%
Shares held by institutions	0.08%
Shares outstanding	44.8M

Metric

Value

Float

14.2M

Shares change (QoQ)

-12.42%

Shares change (YoY)

15.71%

Shares held by insiders

0.45%

Shares held by institutions

0.08%

Shares outstanding

44.8M

EBR/CYAD (EBR/CYAD)

Price

Financial snapshot

Fair-value bridge

Latest news · EBR/CYAD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EBR/CYAD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EBR/CYAD

Frequently asked questions